Simvastatin
lipid-lowering medication
Expert discussions of Simvastatin across 6 podcasts.
Build a research pod, ask cited questions across all of them, and connect it to Claude or ChatGPT.
Common Themes
Videos Mentioning Simvastatin

#129 - Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology
Peter Attia MD
An older statin mentioned as one that Peter Attia rarely prescribes due to its safety profile compared to newer alternatives.

#27 – David Sinclair, Ph.D.: Slowing aging – sirtuins, NAD, and the epigenetics of aging
Peter Attia MD
A statin drug that was part of some ITPs (Interventions Testing Program) at NIA, alongside rapamycin and resveratrol, though its inclusion was questioned by Peter Attia.

#23–Tom Dayspring Part IV of V: statins, Zetia, PCSK9 inhibitors, niacin, cholesterol & the brain
Peter Attia MD
A statin that reduced clinical events in Swedish MI survivors by 25%. Its 80mg dose was later taken off the market due to drug interactions.

#07 – Deep Dive: Lp(a) — what every doctor, and the 10-20% of the population at risk, needs to know
Peter Attia MD
A statin medication that, according to some studies, may trend towards increasing Lp(a) levels.

255-Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease, familial hypercholesterolemia
Peter Attia MD
A statin used in trials for children with heterozygous FH.

409 ‒ Inside modern drug development: the science, economics, and regulatory hurdles
Peter Attia MD
An older statin drug, mentioned in the context of incremental improvements in drug development.